Literature DB >> 36268233

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma.

Margaret L P Teng1, Kai En Chan2, Darren J H Tan2, Daniel Q Huang1,2.   

Abstract

Entities:  

Year:  2022        PMID： 36268233      PMCID： PMC9578000          DOI： 10.21037/hbsn-22-362

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  16 in total

1.  AASLD guidelines for the treatment of hepatocellular carcinoma.

Authors:  Julie K Heimbach; Laura M Kulik; Richard S Finn; Claude B Sirlin; Michael M Abecassis; Lewis R Roberts; Andrew X Zhu; M Hassan Murad; Jorge A Marrero
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

2.  Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.

Authors:  O Simmons; D T Fetzer; T Yokoo; J A Marrero; A Yopp; Y Kono; N D Parikh; T Browning; A G Singal
Journal:  Aliment Pharmacol Ther       Date:  2016-11-08       Impact factor: 8.171

3.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

4.  Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study.

Authors:  Daniel Q Huang; Kathryn J Fowler; Joy Liau; Guilherme M Cunha; Ashley L Louie; Julie Y An; Ricki Bettencourt; Jinho Jung; Zachary Gitto; Christie Hernandez; Scarlett J Lopez; Hersh Gupta; Claude B Sirlin; Robert M Marks; Rohit Loomba
Journal:  Aliment Pharmacol Ther       Date:  2022-02-28       Impact factor: 8.171

5.  Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.

Authors:  Darren Jun Hao Tan; Veronica Wendy Setiawan; Cheng Han Ng; Wen Hui Lim; Mark D Muthiah; Eunice X Tan; Yock Young Dan; Lewis R Roberts; Rohit Loomba; Daniel Q Huang
Journal:  Hepatology       Date:  2022-08-29       Impact factor: 17.298

6.  Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients.

Authors:  Jin Hean Koh; Darren Jun Hao Tan; Yuki Ong; Wen Hui Lim; Cheng Han Ng; Phoebe Wen Lin Tay; Jie Ning Yong; Mark D Muthiah; Eunice X Tan; Ning Qi Pang; Beom Kyung Kim; Nicholas Syn; Alfred Kow; Brian K P Goh; Daniel Q Huang
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 8.265

Review 7.  Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.

Authors:  Daniel Q Huang; Hashem B El-Serag; Rohit Loomba
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-12-21       Impact factor: 46.802

Review 8.  Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians.

Authors:  Daniel Geh; Derek M Manas; Helen L Reeves
Journal:  Hepatobiliary Surg Nutr       Date:  2021-01       Impact factor: 8.265

9.  Global and regional long-term survival following resection for HCC in the recent decade: A meta-analysis of 110 studies.

Authors:  Rosyli F Reveron-Thornton; Margaret L P Teng; Eunice Yewon Lee; Andrew Tran; Sean Vajanaphanich; Eunice X Tan; Sanjna N Nerurkar; Rui Xin Ng; Readon Teh; Debi Prasad Tripathy; Takanori Ito; Taku Tanaka; Nozomi Miyake; Biyao Zou; Connie Wong; Hidenori Toyoda; Carlos O Esquivel; C Andrew Bonham; Mindie H Nguyen; Daniel Q Huang
Journal:  Hepatol Commun       Date:  2022-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.